Insider Trading March 2, 2026

Indie Semiconductor CEO Disposes of $322,846 in INDI Shares; Exercises Options for 186,835 Shares

McClymont sells 90,644 Class A shares and simultaneously exercises RSU-related options as company navigates losses and analyst adjustments

By Jordan Park INDI
Indie Semiconductor CEO Disposes of $322,846 in INDI Shares; Exercises Options for 186,835 Shares
INDI

Indie Semiconductor Chief Executive Officer Donald McClymont sold 90,644 shares of Class A Common Stock on March 2, 2026 for $3.5617 per share, generating $322,846 in proceeds. On the same day he exercised options to acquire 186,835 shares upon the vesting of Restricted Stock Units. The stock trades at $3.39 and carries a beta of 2.54, while the company reports a negative gross profit margin of -31% over the last twelve months. Separately, Indie secured a software supply deal with Mahindra & Mahindra for in-cabin monitoring, and UBS trimmed its price target to $4.25 from $5.00 but kept a Neutral rating.

Key Points

  • CEO Donald McClymont sold 90,644 Class A shares on March 2, 2026 at $3.5617 per share, netting $322,846.
  • On the same date, McClymont exercised options to acquire 186,835 Class A shares upon RSU vesting; the stock trades at $3.39 and has a beta of 2.54.
  • Indie faces profitability pressure with a -31% gross profit margin over the last twelve months, while securing a software supply deal with Mahindra and receiving a reduced near-term price target from UBS.

Indie Semiconductor (NASDAQ: INDI) CEO Donald McClymont completed two transactions on March 2, 2026 that together altered his direct holdings in the company. In two separate sales executed that day, McClymont disposed of a total of 90,644 shares of Class A Common Stock at a price of $3.5617 per share, yielding proceeds of $322,846.

Also on March 2, McClymont exercised options to acquire 186,835 shares of Class A Common Stock upon the vesting of Restricted Stock Units. Both the sale and the option exercise occurred in the same trading session.


Indie’s publicly quoted share price stood at $3.39 at the time of reporting, and the company’s beta is 2.54, indicating the stock has traded with significantly greater volatility than the broader market. Financially, the firm reported a negative gross profit margin of -31% over the prior twelve months, underscoring ongoing profitability challenges.

In operational news, Indie Semiconductor has been chosen by Mahindra & Mahindra Limited to supply in-cabin monitoring software for the automaker’s Electric Origin SUVs, specifically the XEV 9e and BE 6. The deal calls for integration of Indie’s CABIN EYE perception software, produced by its emotion3D unit, with Mahindra’s EyeDentity hardware platform.

On the analyst front, UBS adjusted its outlook for Indie Semiconductor by reducing its price target to $4.25 from $5.00 while retaining a Neutral rating. The firm slightly lowered its earnings per share estimate to $0.27 from $0.28. UBS also noted higher projections for 2028 and periods beyond, despite the nearer-term revision.


For investors seeking deeper financial analysis, InvestingPro is noted as offering Fair Value estimates and research reports covering a wide set of U.S. equities, including detailed models and commentary on companies such as Indie Semiconductor.

The sequence of insider selling, option exercises, persistent negative gross margin, a high trading beta, the Mahindra partnership, and UBS’s revised near-term estimates together present a range of data points market participants can weigh when assessing Indie’s near-term positioning and longer-term outlook.

Risks

  • Profitability risk - the company reported a negative gross profit margin of -31% for the last twelve months, indicating continued operating and margin challenges for the semiconductor sector.
  • Market volatility risk - INDI’s beta of 2.54 signals substantially higher price swings relative to the broader market, affecting investors in semiconductor and tech-related equities.
  • Analyst uncertainty - UBS lowered its price target to $4.25 from $5.00 and slightly cut near-term EPS estimates, reflecting cautious near-term analyst expectations which could influence market perception.

More from Insider Trading

Marvell Technology President Sells $1.1M in Stock as Shares Trade Near Yearly High Apr 6, 2026 Edward Lampert Sells $58.5 Million in Lands’ End Stock; Company Posts Q4 Shortfall, Announces $100M Buyback Program Apr 6, 2026 NeonC/NeOnc President Buys $153,398 in Stock as Company Advances Financing and Clinical Timeline Apr 6, 2026 Edwards Lifesciences Executive Executes Option Exercise, Sells 1,019 Shares Apr 6, 2026 Penumbra Director Executes $32,822 Stock Sale Amid Deal and Upbeat Quarterly Results Apr 6, 2026